These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30730841)

  • 1. The effect of PKU diet on the maternal quality of life and social discrimination in relation to their educational status and place of living.
    Iakovou K; Madoglou A; Monopolis I; Schulpis K
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):281-285. PubMed ID: 30730841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beneficial effect of psychological support on mothers with PKU children who suffer from social discrimination and damage of quality of life.
    Iakovou KK; Schulpis K
    J Pediatr Endocrinol Metab; 2020 Jan; 33(1):95-98. PubMed ID: 31811806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial functioning in children with phenylketonuria: Relationships between quality of life and parenting indicators.
    Morawska A; Mitchell AE; Etel E; Kirby G; McGill J; Coman D; Inwood A
    Child Care Health Dev; 2020 Jan; 46(1):56-65. PubMed ID: 31782540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everyday Life, Dietary Practices, and Health Conditions of Adult PKU Patients: A Multicenter, Cross-Sectional Study.
    Klimek A; Baerwald C; Schwarz M; Rutsch F; Parhofer KG; Plöckinger U; Heddrich-Ellerbrok M; Vom Dahl S; Schöne K; Ott M; Lang F; Hennermann JB
    Ann Nutr Metab; 2020; 76(4):251-258. PubMed ID: 32998147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.
    Bosch AM; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Koledova E; Benmedjahed K; Regnault A
    Orphanet J Rare Dis; 2015 Jun; 10():80. PubMed ID: 26084935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome at age 4 years in offspring of women with maternal phenylketonuria: the Maternal PKU Collaborative Study.
    Waisbren SE; Hanley W; Levy HL; Shifrin H; Allred E; Azen C; Chang PN; Cipcic-Schmidt S; de la Cruz F; Hall R; Matalon R; Nanson J; Rouse B; Trefz F; Koch R
    JAMA; 2000 Feb; 283(6):756-62. PubMed ID: 10683054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study.
    Demirdas S; Maurice-Stam H; Boelen CC; Hofstede FC; Janssen MC; Langendonk JG; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; de Vries M; Grootenhuis MA; Bosch AM
    Mol Genet Metab; 2013; 110 Suppl():S49-56. PubMed ID: 24100246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of phenylketonuria on PKU patients' quality of life: Using of the phenylketonuria-quality of life (PKU-QOL) questionnaires.
    Alptekin IM; Koc N; Gunduz M; Cakiroglu FP
    Clin Nutr ESPEN; 2018 Oct; 27():79-85. PubMed ID: 30144897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria.
    Bosch AM; Tybout W; van Spronsen FJ; de Valk HW; Wijburg FA; Grootenhuis MA
    J Inherit Metab Dis; 2007 Feb; 30(1):29-34. PubMed ID: 17160615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.
    Cechák P; Hejcmanová L; Rupp A
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S59-63. PubMed ID: 8828612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence.
    Enns GM; Koch R; Brumm V; Blakely E; Suter R; Jurecki E
    Mol Genet Metab; 2010; 101(2-3):99-109. PubMed ID: 20678948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Resource Mothers Study of Maternal Phenylketonuria: preliminary findings.
    Rohr F; Munier A; Sullivan D; Bailey I; Gennaccaro M; Levy H; Brereton H; Gleason S; Goss B; Lesperance E; Moseley K; Singh R; Tonyes L; Vespa H; Waisbren S
    J Inherit Metab Dis; 2004; 27(2):145-55. PubMed ID: 15159645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does maternal knowledge and parent education affect blood phenylalanine control in phenylketonuria?
    Macdonald A; Davies P; Daly A; Hopkins V; Hall SK; Asplin D; Hendriksz C; Chakrapani A
    J Hum Nutr Diet; 2008 Aug; 21(4):351-8. PubMed ID: 18721402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behaviour and school achievement in patients with early and continuously treated phenylketonuria.
    Stemerdink BA; Kalverboer AF; van der Meere JJ; van der Molen MW; Huisman J; de Jong LW; Slijper FM; Verkerk PH; van Spronsen FJ
    J Inherit Metab Dis; 2000 Sep; 23(6):548-62. PubMed ID: 11032330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation and Validation of a Questionnaire to Evaluate Knowledge of the Low Phe Diet in PKU.
    Ramos-Álvarez R; Kapp M; Rodríguez-Ruiz MM; Fausor R; Bueno-Delgado MA; Ahring K; Waisbren SE
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires.
    Regnault A; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Benmedjahed K; Bosch AM
    Orphanet J Rare Dis; 2015 May; 10():59. PubMed ID: 25958326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to diet and quality of life in patients with phenylketonuria.
    Cotugno G; Nicolò R; Cappelletti S; Goffredo BM; Dionisi Vici C; Di Ciommo V
    Acta Paediatr; 2011 Aug; 100(8):1144-9. PubMed ID: 21342250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of metabolic control and tetrahydrobiopterin treatment on health related quality of life of patients with early-treated phenylketonuria: A PKU-COBESO study.
    Huijbregts SCJ; Bosch AM; Simons QA; Jahja R; Brouwers MCGJ; De Sonneville LMJ; De Vries MC; Hofstede FC; Hollak CEM; Janssen MCH; Langendonk JG; Rubio-Gozalbo ME; Van der Meere JJ; Van der Ploeg AT; Van Spronsen FJ
    Mol Genet Metab; 2018 Sep; 125(1-2):96-103. PubMed ID: 30007854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mealtime Anxiety and Coping Behaviour in Parents and Children During Weaning in PKU: A Case-Control Study.
    Evans S; Daly A; Wildgoose J; Cochrane B; Ashmore C; Kearney S; MacDonald A
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31766512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.